资源类型:
会议/期刊
收录情况:
◇ SCIE
◇ CPCI(ISTP)
文章类型:
会议摘要
作者:
Chen, Wenming[1]
*
;
Fu, Chengcheng[2]
;
Fang, Baijun[3,4]
;
Liang, Aibin[5]
;
Xia, Zhongjun[6]
;
He, Yanjuan[7]
;
Lu, Jin[8]
;
Liu, Hui[9]
;
Hou, Ming[10]
;
Cai, Zhen[11]
;
Yang, Wei[12]
;
Hao, Siguo[13]
;
Jiang, Songfu[14]
;
Jing, Hongmei[15]
;
Liu, Jing[16]
;
Du, Xin[17]
;
Fu, Rong[18]
;
Mei, Heng[19]
;
Zhu, Zunmin[20]
;
Yang, Yanli[21,22]
;
Liu, Hong[23]
;
Yuan, Daijing[24]
;
Zhao, Hongxia[24]
;
Xiao, Jun[24]
;
Wang, Wei[24]
;
Wang, Huamao[24]
;
Li, Zonghai[24]
;
单位:
[1]Capital Med Univ, Beijing Chao Yang Hosp, Dept Hematol, Beijing, Peoples R China
北京朝阳医院
[2]Soochow Univ, Affilliated Hosp 1, Suzhou, Peoples R China
[3]Zhengzhou Univ, Affiliated Canc Hosp, Dept Hematol, Zhengzhou, Peoples R China
河南省肿瘤医院
[4]Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China
[5]Tongji Univ, Tongji Hosp, Sch Med, Shanghai, Peoples R China
[6]Sun Yat Sen Univ, Canc Ctr, Dept Hematol Oncol, State Key Lab Oncol South China,Collaborat Innova, Guangzhou, Peoples R China
[7]Cent South Univ, Xiangya Hosp, Dept Hematol, Changsha, Peoples R China
[8]Peking Univ, Inst Hematol, Beijing, Peoples R China
[9]Beijing Hosp, Dept Hematol, Beijing, Peoples R China
[10]Shandong Univ, Qilu Hosp, Dept Hematol, Jinan, Peoples R China
[11]Zhejiang Univ, Affiliated Hosp 1, Sch Med, Bone Marrow Transplantat Ctr, Hangzhou, Peoples R China
浙江大学医学院附属第一医院
[12]China Med Univ, Shengjing Hosp, Shenyang, Peoples R China
中国医科大学附属盛京医院
中国医科大学盛京医院
[13]Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Shanghai, Peoples R China
[14]Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Peoples R China
[15]Peking Univ Third Hosp, Dept Hematol, Beijing, Peoples R China
[16]Cent South Univ, Xiangya Hosp 3, Dept Hematol, Changsha, Peoples R China
[17]Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Div Hematol, Shenzhen, Peoples R China
[18]Tianjin Med Univ Gen Hosp, Dept Hematol, Tianjin, Peoples R China
[19]Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Inst Hematol, Wuhan, Peoples R China
华中科技大学同济医学院附属协和医院
[20]Henan Prov Peoples Hosp, Dept Hematol, Zhengzhou, Peoples R China
[21]Bengbu Med Collegue, Affiliated Hosp 1, Bengbu, Peoples R China
[22]Bengbu Med Collegue, Affiliated Hosp 1, Nantong, Peoples R China
[23]Nantong Univ, Affiliated Hosp, Nantong, Peoples R China
[24]CARsgen Therapeut Co Ltd, Shanghai, Peoples R China
ISSN:
0006-4971
被引次数:
8
WOS:
WOS:000893223204259
中科院(CAS)分区:
出版当年[2021]版:
大类
|
1 区
医学
小类
|
1 区
血液学
最新[2025]版:
大类
|
1 区
医学
小类
|
1 区
血液学
JCR分区:
出版当年[2020]版:
Q1
HEMATOLOGY
影响因子:
21.1
最新[2023版]
19.2
最新五年平均
23.629
出版当年[2020版]
20.107
出版当年五年平均
17.794
出版前一年[2019版]
25.669
出版后一年[2021版]
第一作者:
Chen, Wenming
第一作者单位:
[1]Capital Med Univ, Beijing Chao Yang Hosp, Dept Hematol, Beijing, Peoples R China
推荐引用方式(GB/T 7714):
Chen Wenming,Fu Chengcheng,Fang Baijun,et al.Phase II Study of Fully Human BCMA-Targeting CAR-T Cells (Zevorcabtagene Autoleucel) in Patients with Relapsed/ Refractory Multiple Myeloma[J].BLOOD.2022,140:4564-4565.doi:10.1182/blood-2022-168610.
APA:
Chen, Wenming,Fu, Chengcheng,Fang, Baijun,Liang, Aibin,Xia, Zhongjun...&Li, Zonghai.(2022).Phase II Study of Fully Human BCMA-Targeting CAR-T Cells (Zevorcabtagene Autoleucel) in Patients with Relapsed/ Refractory Multiple Myeloma.BLOOD,140,
MLA:
Chen, Wenming,et al."Phase II Study of Fully Human BCMA-Targeting CAR-T Cells (Zevorcabtagene Autoleucel) in Patients with Relapsed/ Refractory Multiple Myeloma".BLOOD 140.(2022):4564-4565